Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: A modular phase I trial in androgen-independent prostate cancer [14]

Matthias D. Hofer; Mark A. Rubin

doi:10.1200/JCO.2005.05.274

Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: A modular phase I trial in androgen-independent prostate cancer [14]

Matthias D. Hofer^*, Mark A. Rubin

^*Corresponding author for this work

Urology

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	1332-1333
Number of pages	2
Journal	Journal of Clinical Oncology
Volume	23
Issue number	6
DOIs	https://doi.org/10.1200/JCO.2005.05.274
State	Published - Feb 20 2005

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.2005.05.274

Cite this

@article{5cd248d879de4ea7a9986a5c14ead3cd,

title = "Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: A modular phase I trial in androgen-independent prostate cancer [14]",

author = "Hofer, {Matthias D.} and Rubin, {Mark A.}",

year = "2005",

month = feb,

day = "20",

doi = "10.1200/JCO.2005.05.274",

language = "English (US)",

volume = "23",

pages = "1332--1333",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel

T2 - A modular phase I trial in androgen-independent prostate cancer [14]

AU - Hofer, Matthias D.

AU - Rubin, Mark A.

PY - 2005/2/20

Y1 - 2005/2/20

UR - http://www.scopus.com/inward/record.url?scp=14544293567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14544293567&partnerID=8YFLogxK

U2 - 10.1200/JCO.2005.05.274

DO - 10.1200/JCO.2005.05.274

M3 - Letter

C2 - 15718346

AN - SCOPUS:14544293567

SN - 0732-183X

VL - 23

SP - 1332

EP - 1333

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 6

ER -

Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: A modular phase I trial in androgen-independent prostate cancer [14]

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this